scholarly journals Tuning DNA–nanoparticle conjugate properties allows modulation of nuclease activity

Nanoscale ◽  
2021 ◽  
Vol 13 (9) ◽  
pp. 4956-4970
Author(s):  
Jeff C. Hsiao ◽  
Tomas Buryska ◽  
Eunjung Kim ◽  
Philip D. Howes ◽  
Andrew J. deMello

A systematic study of the interactions between nucleases and oligonucleotide-coated gold nanoparticles (spherical nucleic acids, SNAs) demonstrates that the modular units of SNAs can be leveraged to either accelerate or suppress nuclease kinetics.

2021 ◽  
Vol 143 (3) ◽  
pp. 1296-1300
Author(s):  
Yang Fang ◽  
Xueguang Lu ◽  
Dali Wang ◽  
Jiansong Cai ◽  
Yuyan Wang ◽  
...  

ACS Nano ◽  
2021 ◽  
Author(s):  
Ziyin N. Huang ◽  
Cassandra E. Callmann ◽  
Lisa E. Cole ◽  
Shuya Wang ◽  
Chad A. Mirkin

Author(s):  
Vijay Gulumkar ◽  
Antti Äärelä ◽  
Olli Moisio ◽  
Jani Rahkila ◽  
Ville Tähtinen ◽  
...  

2020 ◽  
Vol 13 (11) ◽  
pp. 360
Author(s):  
Thomas R. Holmes ◽  
Amy S. Paller

Spherical nucleic acids (SNAs) are nanostructures consisting of nucleic acids in a spherical configuration, often around a nanoparticle core. SNAs are advantageous as gene-regulating agents compared to conventional gene therapy owing to their low toxicity, enhanced stability, uptake by virtually any cell, and ability to penetrate the epidermal barrier. In this review we: (i) describe the production, structure and properties of SNAs; (ii) detail the mechanism of SNA uptake in keratinocytes, regulated by scavenger receptors; and (iii) report how SNAs have been topically applied and intralesionally injected for skin disorders. Specialized SNAs called nanoflares can be topically applied for gene-based diagnosis (scar vs. normal tissue). Topical SNAs directed against TNFα and interleukin-17A receptor reversed psoriasis-like disease in mouse models and have been tested in Phase 1 human trials. Furthermore, SNAs targeting ganglioside GM3 synthase accelerate wound healing in diabetic mouse models. Most recently, SNAs targeting toll-like receptor 9 are being used in Phase 2 human trials via intratumoral injection to induce immune responses in Merkel cell and cutaneous squamous cell carcinoma. Overall, SNAs are a valuable tool in bench-top and clinical research, and their advantageous properties, including penetration into the epidermis after topical delivery, provide new opportunities for targeted therapies.


Science ◽  
2015 ◽  
Vol 349 (6253) ◽  
pp. 1150-1151 ◽  
Author(s):  
Robert F. Service

2019 ◽  
Vol 127 ◽  
pp. 85-91 ◽  
Author(s):  
Lu Wang ◽  
Huan Zhang ◽  
Chenguang Wang ◽  
Yi Xu ◽  
Jing Su ◽  
...  

Author(s):  
Marie Held ◽  
Raphael Levy

<p>From the 1950s onwards, our understanding of the formation and intracellular trafficking of membrane vesicles was informed by experiments in which cells were exposed to gold nanoparticles and their uptake and localisation, studied by electron microscopy.&nbsp; In the last decade, building on progress in the synthesis of gold nanoparticles and their controlled functionalisation with a large variety of biomolecules (DNA, peptides, polysaccharides), new applications have been proposed, including the imaging and sensing of intracellular events. Yet, as already demonstrated in the 1950s, uptake of nanoparticles results in confinement within an intracellular vesicle which in principle should preclude sensing of cytosolic events. To study this apparent paradox, we focus on a commercially available nanoparticle probe that detects mRNA through the release of a fluorescently-labelled oligonucleotide (unquenching the fluorescence) in the presence of the target mRNA. Using electron, fluorescence and photothermal microscopy, we show that the probes remain in endocytic compartments and that they do not report on mRNA level. We suggest that the validation of any nanoparticle-based probes for intracellular sensing should include a quantitative and thorough demonstration that the probes can reach the cytosolic compartment.</p>


Sign in / Sign up

Export Citation Format

Share Document